CMS Finalizes Spending Per Beneficiary Quality Measure Over MDMA Objections
Executive Summary
The US Medicare agency in its final 2019 Inpatient Prospective Payment System rule plans to continue assessing patients’ outcomes under its Hospital Value-Based Program in part with a Medicare spending per beneficiary measure, despite industry warnings that doing so may sacrifice patient quality of care.
You may also be interested in...
Three Devices Gain Medicare Add-Ons, Including Boston Sci's New TAVR Protector
The US Medicare agency granted inpatient new-technology add-on payments for Boston Scientific's newly acquired cerebral protection system for TAVR, Respicardia's neurostimulator for sleep apnea and Procept BioRobotics' novel resection system for benign prostatic hyperplasia. The highly selective bonus payments typically help drive adoption for the chosen new technologies.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.